These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22433929)

  • 21. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of growth failure and other endocrine aspects in patients with Noonan syndrome across Europe: A sub-analysis of a European clinical practice survey.
    Edouard T; Zenker M; Östman-Smith I; Ortega Castelló E; Wolf CM; Burkitt-Wright E; Verloes A; García-Miñaúr S; Tartaglia M; Shaikh G; Lebl J
    Eur J Med Genet; 2022 Jan; 65(1):104404. PubMed ID: 34896604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.
    Chaplin JE; Kriström B; Jonsson B; Hägglöf B; Tuvemo T; Aronson AS; Dahlgren J; Albertsson-Wikland K
    Horm Res Paediatr; 2011; 75(4):291-303. PubMed ID: 21304250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
    Ranke MB; Schweizer R; Martin DD; Ehehalt S; Schwarze CP; Serra F; Binder G
    Horm Res Paediatr; 2012; 77(4):214-21. PubMed ID: 22433161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
    Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acromegaly induced by growth hormone replacement therapy.
    Karges B; Pfäffle R; Boehm BO; Karges W
    Horm Res; 2004; 61(4):165-9. PubMed ID: 14707471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult growth hormone deficiency guidelines: more difficult than it seems to incorporate into clinical practice universally.
    Yuen KCJ
    Eur J Endocrinol; 2021 Apr; 184(4):C5-C7. PubMed ID: 33524002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children.
    Haverkamp F; Gasteyger C
    J Med Econ; 2011; 14(4):448-57. PubMed ID: 21651428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A lifetime of growth hormone deficiency: a US pediatric perspective.
    Saenger P
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1337-42. PubMed ID: 11202206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating clinical guidelines into practice: the effective and appropriate use of human growth hormone.
    Navarro R; Dunn JD; Lee PA; Owens GM; Rapaport R
    Am J Manag Care; 2013 Nov; 19(15 Suppl):s281-9. PubMed ID: 24494610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus document of the Neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition on management of hypopituitarism during transition.
    Alvarez-Escolá C; Fernández-Rodríguez E; Recio-Córdova JM; Bernabéu-Morón I; Fajardo-Montañana C;
    Endocrinol Nutr; 2014 Feb; 61(2):68.e1-68.e11. PubMed ID: 24200635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
    Bakker B; Frane J; Anhalt H; Lippe B; Rosenfeld RG
    J Clin Endocrinol Metab; 2008 Feb; 93(2):352-7. PubMed ID: 18000092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coming Up Short: Risks of Bias in Assessing Psychological Outcomes in Growth Hormone Therapy for Short Stature.
    Gardner M; Boshart ML; Yeguez CE; Desai KM; Sandberg DE
    J Clin Endocrinol Metab; 2016 Jan; 101(1):23-30. PubMed ID: 26583584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone therapy: emerging dilemmas.
    Laron Z
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):364-73. PubMed ID: 21972776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.